H. Lundbeck A/S held its Annual General Meeting on 21 April 2008 at the company's registered office

At the general meeting the report by the Supervisory Board and the
Annual Report were approved, and the Supervisory Board and Executive
Management were discharged from liability.

The general meeting approved the dividend of DKK 2.30 per share of
DKK 5 nominal value proposed by the Supervisory Board.

Per Wold-Olsen, Thorleif Krarup, Peter Kürstein, Mats Pettersson, Jes
Østergaard and Egil Bodd were all re-elected to the Supervisory
Board. Immediately after the general meeting, the Supervisory Board
elected Per Wold-Olsen Chairman and Thorleif Krarup Deputy Chairman
of the Supervisory Board.

After having elected its Chairman and Deputy Chairman, the
Supervisory Board appointed members for the Audit Committee and the
Remuneration Committee.

Peter Kürstein, Egil Bodd and Thorleif Krarup were re-elected as
members of the Audit Committee. Per Wold-Olsen, Jes Østergaard and
Mats Pettersson were re-elected as members of the Remuneration
Committee.

The Supervisory Board of H. Lundbeck A/S will hereafter comprise:

-                     Per Wold-Olsen
-                     Thorleif Krarup
-                     Peter Kürstein
-                     Mats Pettersson
-                     Jes Østergaard
-                     Egil Bodd
-                     Birgit Bundgaard Rosenmeier (employee
representative)
-                     Jens Møller Mayntzhusen (employee
representative)
-                     Kim Rosenville Christensen (employee
representative)

Deloitte Statsautoriseret Revisionsaktieselskab was re-appointed as
the company's auditor.

The Supervisory Board's proposed resolutions under item 6 of the
agenda were adopted. Consequently, a resolution was adopted to reduce
the share capital of the company by DKK 3,848,240 nominal value of
the company's holding of treasury shares acquired from shareholders
of the company as part of the implementation of share buyback
programmes. The proposal was adopted to change the deadline for the
Board's exercise of its authorisation under Article 4.1 from "until
30 March 2009" to "until 30 March 2014". A new Article 16.0 was
inserted in the Articles of Association with a provision governing
electronic communication and Article 7.1 was amended accordingly.
Finally, the chairman of the general meeting was authorised to make
such changes in and supplements to the resolutions adopted by the
general meeting and the notification to the Danish Commerce and
Companies Agency as may be requested by the Commerce and Companies
Agency in connection with its registration of the amendments made.

No other business was transacted at the general meeting.

Supervisory Board


The content of this release will have no influence on the Lundbeck
Group's financial result for 2009.


Lundbeck contacts


Investors:                   Media:

Jacob Tolstrup               Mads Kronborg
Director, IR & Communication Media Relations
+45 36 43 30 79              +45 36 43 28 51

Palle Holm Olesen
Head of Investor Relations
+45 36 43 24 26


About Lundbeck
H. Lundbeck A/S (LUN.CO, LUN DC, HLUKY) is an international
pharmaceutical company engaged in the research and development,
production, marketing and sale of pharmaceuticals for the treatment
of psychiatric and neurological disorders. In 2008, the company's
revenue was DKK 11.3 billion (approximately EUR 1.5 billion or USD
2.2 billion). The number of employees is approx. 5,500 globally. For
more information, please visit www.lundbeck.com.